Records containing: Rheumatoid Arthritis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-09Rheumatology Biorepository
-
CLINICAL_TRIALS study record update · 2026-02-06Improving Hypertension Control for Patients With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2026-02-05A Multi-center, Open, Randomized, 18-month, Parallel-group, Superiority Study to Compare the Effect of Proactive Therapeutic Drug Monitoring Versus Standard of Care With Regards to Maintenance of Sustained Disease Control Without Flare in Adults With Rheumatoid Arthritis Treated With a Subcutaneous Tumor Necrosis Factor Inhibitor
-
CLINICAL_TRIALS study record update · 2026-02-04Transcendence Research: Holistic Education For Colonized Countries Primarily English Speaking
-
CLINICAL_TRIALS study record update · 2026-02-03Coronary Computed Tomography Angiography In Rheumatoid Arthritis Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-03Innovative Trial Designs, Multi-omics and Advanced Computational Prediction to Transform Clinical Care in RA
-
CLINICAL_TRIALS study record update · 2026-02-03Study During Pregnancy of miRNAs in Rheumatoid Arthritis or Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2026-01-30A Multi-Centre Study in Patients Undergoing Total Knee Replacement With Smith+Nephew Porous Total Knee Arthroplasty (TKA) System
-
CLINICAL_TRIALS study record update · 2026-01-29Combining a CD40L-Binding Protein (VIB4920) With a TNF-alpha Inhibitor for the Treatment of Inadequately Controlled Rheumatoid Arthritis (ITN092AI)
-
CLINICAL_TRIALS study record update · 2026-01-22Prospective Evaluation of Baricitinib's Effects on Procoagulant State and Atherogenic Index in Rheumatoid Arthritis Patients
-
CLINICAL_TRIALS study record update · 2026-01-22Investigation of the Relationships Between Core Endurance, Finger Grip Strength, Fatigue, and Hand Function in Patients With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2026-01-21A Phase 1b, Randomized, Blinded, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of GS-0151 in Adult Participants With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2026-01-21ROSA Total Knee Post Market Study: a Prospective, Multicenter EMEA Post Market Clinical Follow up of the ROSA Knee System
-
CLINICAL_TRIALS study record update · 2026-01-21Kinetics of Elimination of Methotrexate and Its Major Metabolite 7-OH-methotrexate for Observant Patients
-
CLINICAL_TRIALS study record update · 2026-01-21Lipids, Inflammation, and Cardiovascular Risk in Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2026-01-20Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2026-01-20Persona® OsseoTi® Keel Compatibility Study-A Multicenter Cohort Study A Prospective, Post-market Clinical Follow-up Study to Demonstrate Safety, Performance and Clinical Benefits of the Persona Knee System Portfolio and Its Instrumentation
-
CLINICAL_TRIALS study record update · 2026-01-16CLEC10A-Targeted M2 Macrophage Repolarization With EF-M2 (Immutalon) in Patients With Moderate-to-Severe Rheumatoid Arthritis: An Open-Label, Multicenter, First-in-Human Phase I/IIa Multiple Ascending Dose Study
-
CLINICAL_TRIALS study record update · 2026-01-15Evaluation of the Switch From the Original Infliximab ( REMICADE®) to Its Biosimilar (INFLECTRA®) in Daily Practice at Cochin Hospital
-
CLINICAL_TRIALS study record update · 2026-01-14A Randomized Double-Blind Placebo-controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of LNK01001 (Zemprocitinib) in Patient With Moderate-to-Severe Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs (COURAGE-RA)
-
CLINICAL_TRIALS study record update · 2026-01-13Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial.
-
CLINICAL_TRIALS study record update · 2026-01-13A Phase 1, Multicenter, Open-Label Study Of CC-97540 (BMS-986353), CD19-Targeted Nex-T Chimeric Antigen Receptor (CAR) T Cells, in Participants With Severe, Refractory Autoimmune Diseases: Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, Systemic Sclerosis, or Rheumatoid Arthritis (Breakfree-1)
-
CLINICAL_TRIALS study record update · 2026-01-13Association Between Severity of Periodontitis and the Level of Anti-citrullinated Protein Antibodies (ACPAs) in Rheumatoid Arthritis Patients
-
CLINICAL_TRIALS study record update · 2026-01-12A Phase 3b/4 Randomized, Double-Blind, Double Dummy, Active Comparator-Controlled Study, Comparing the Efficacy and Safety of Upadacitinib Versus Adalimumab in Subjects With Moderate to Severe Rheumatoid Arthritis on a Stable Background of MTX and Who Had an Inadequate Response or Intolerance to a Single TNF Inhibitor (SELECT- SWITCH)
-
CLINICAL_TRIALS study record update · 2026-01-09An Evaluator-blinded Randomized Controlled Trial Study of the Effect of Anti-inflammatory Diet in Subjects With Rheumatoid Arthritis.